1.
Nafian F, Yazdani S, Javad Rasaee M, Kamali Doust Azad B, Daftarian N, Rezaei Kanavi M. Modification of a Selective NTRK2 Agonist and Confirmation of Activity in a Glaucoma-on-a-Chip Model. JOVR [Internet]. 2024Mar.10 [cited 2024May14];19(1):58–70. Available from: https://knepublishing.com/index.php/JOVR/article/view/15439